(Q44805128)

6 December 2017

Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen (English)

1 reference

6 December 2017

0 references

A-K L Robertson

1

1 reference

6 December 2017

X Zhou

series ordinal

2

1 reference

6 December 2017

B Strandvik

series ordinal

3

1 reference

6 December 2017

G K Hansson

series ordinal

4

1 reference

6 December 2017

1 March 2004

1 reference

Scandinavian Journal of Immunology

6 December 2017

1 reference

6 December 2017

59

1 reference

6 December 2017

285-293

1 reference

6 December 2017

3

1 reference

IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice

6 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Antigen and antibody detection by in vivo methods; A reevaluation of passive cutaneous anaphylactic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

The role of interleukin-4 in the regulation of sequential isotype switch from immunoglobulin G1 to immunoglobulin E antibody production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Differential regulation of mouse germline Ig gamma 1 and epsilon promoters by IL-4 and CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Peroxisome proliferator-activated receptor γ activators inhibit interleukin-12 production in murine dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Protective Role of Interleukin-10 in Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Cytokine secretion profiles of cloned T cells from human aortic atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Improved high-performance liquid chromatographic method for the separation and quantification of lipid classes: application to fish lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Heat inactivation of rat and mouse IgE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Oxidative modification of lipoproteins in hypertriglyceridemic patients and hypercholesterolemic rabbits in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01403.X

10.1111/J.0300-9475.2004.01403.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference